Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00760942 · ClinicalTrials.gov registry record · NA
Liquid Preterm Formula Versus Powdered Human Milk Fortifier in VLBW Infants
A NA study, sponsored by University of Oklahoma.
- Completed
- Registry status
- NA
- Development phase
- 84
- Enrollment target
NCT00760942: Completed NA study, sponsored by University of Oklahoma.
NCT00760942 is a NA study that has completed, run by University of Oklahoma. The registered enrollment target is 84 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00760942, a NA study, has completed, sponsored by University of Oklahoma.
- COMPLETED
- Registry status
- NA
- Development phase
- 84 participants
- Enrollment target
Study Summary
This study aims to compare the short-term effects on growth and feeding tolerance of a liquid high calorie formula added to human milk versus powdered human milk fortifier in small preterm infants.
Interventions
- DIETARY_SUPPLEMENT Similac special care 30
- DIETARY_SUPPLEMENT Similac human milk fortifier
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2008-10 |
| Est. Completion | 2010-09 |
| Phase | NA |
What the finished NCT00760942 record still lists
NCT00760942 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 84 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which Similac special care 30 is the first listed.
NCT00760942 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00760942 about?
NCT00760942 is a clinical study titled "Liquid Preterm Formula Versus Powdered Human Milk Fortifier in VLBW Infants". This study aims to compare the short-term effects on growth and feeding tolerance of a liquid high calorie formula added to human milk versus powdered human milk fortifier in small preterm infants.
What is the current status of trial NCT00760942?
This trial is currently completed. It is a NA study. The enrollment target is 84 participants. The study started on 2008-10. Estimated completion is 2010-09.
What interventions are being tested in trial NCT00760942?
The interventions under investigation include: Similac special care 30 (DIETARY_SUPPLEMENT), Similac human milk fortifier (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00760942?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00760942's enrollment target sits among peer trials
84 983rd of 2000 higher than 1,011 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02391519 · 84 participants
Effects of High Altitude on AMPK Activation
- NCT03838536 · 84 participants · NA
Synergistic Activity of Human Milk Nutrients and Infant Cognition
- NCT03884075 · 84 participants · Phase 2
Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
- NCT03894917 · 84 participants
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia